Literature DB >> 30122007

[Reconsidering on the drug therapy of adult laryngopharyngeal reflux disease].

J J Hu1, M J Zheng1, Y Chen2, L Y Yu1, H Yang1.   

Abstract

The treatment for laryngopharyngeal reflux diseases consist of general treatment, medical therapy and surgical treatment, among which, drug therapy is still the main effective way. Proton pump inhibitor is adopted as the first drug for patients with laryngopharyngeal reflux disease only caused by acid reflux. With standardized treatment, the majority of symptoms in laryngopharyngeal reflux disease could be alleviated effectively. PPI therapy, while seeming logical, is less useful in patients with reflux hypersensitivity, weak acid or non acid reflux, neuropsychic factors and gastroesophageal reflux disease. This article aims to investigate bewilderment and challenge faced by clinicians when managing adult laryngology reflux disease with medical therapy.

Entities:  

Keywords:  Drug therapy; Laryngopharyngeal reflux

Mesh:

Substances:

Year:  2018        PMID: 30122007     DOI: 10.3760/cma.j.issn.1673-0860.2018.08.017

Source DB:  PubMed          Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1673-0860


  2 in total

1.  Correlation Between Refractory Laryngopharyngeal Reflux Disease and Symptoms of Anxiety and Depression.

Authors:  Fengling Huang; Qiu Liao; Xingkun Gan; Wensheng Wen
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-26       Impact factor: 2.989

2.  Proton pump inhibitors for the treatment of laryngopharyngeal reflux disease: A protocol for systematic review and meta-analysis.

Authors:  Xiangyi Liu; Ying Jiang; Haiyan Luo; Haolin Liu
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.